
13 May 2022
Love Hemp Group PLC
("Love Hemp", the "Group", or the "Company")
Update to Announcement of 9 May 2022
Love Hemp Group PLC (AQSE: LIFE) (OTCQB: WRHLF), the brand-led consumer goods company focused on CBD health and wellness solutions, provides a further update at the request of Peterhouse Capital Limited ("Peterhouse").
The announcement released by Love Hemp on 9 May 2022 incorrectly stated that Peterhouse Capital Limited ("Peterhouse") had resigned as the Company's AQSE Corporate Adviser "following the update by the Company that an investor in the February 2022 placing had failed to complete their investment of
Love Hemp wishes to clarify that Peterhouse in fact resigned as the Company's AQSE Corporate Adviser before the release of the Company's update on 3 May 2022 and that the investor who failed to complete their investment of
-ENDS-
For further information please visit: www.lovehempgroup.com or contact:
Love Hemp Group Andrew Male
|
+44 (0) 7926 397 675 andrew.male@lovehempgroup.com
|
Financial Advisor Rupert Fane H&P Advisory Limited |
+44 (0) 20 7907 8500 rf@hannam.partners
|
|
|
Financial PR Tim Blythe/Alice McLaren/Madeleine Gordon-Foxwell BlytheRay
|
+44 (0) 207 138 3204 lovehemp@blytheray.com |
About Love Hemp Group
Love Hemp Group is a brand-led consumer goods company focused on health and wellness solutions for consumer use cases including sleep, pain, anxiety, stress and recovery. The Company is a pioneer in the
Market Abuse Regulation (MAR) Disclosure
The information contained within this announcement is deemed by the Company to constitute inside information. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.